Fresenius Medical Care: A 'Buy' Going Into 2025
Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a ...
Psychology Today16h
Ozempic for the Rich, Body Positivity for the Poor
Moreover, the stigma surrounding obesity disproportionately affects lower-income individuals, who are often blamed for their ...
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
CNN on MSN9d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce certain risks associated with chronic kidney disease.
The New York Times7d
Ozempic May Protect Against Alzheimer’s
By Dana G. Smith and Dani Blum Over a decade ago, a smattering of studies suggested that early cousins of drugs like Ozempic and Mounjaro could prevent, or even reverse, signs of Alzheimer’s ...
CNN9d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was ... But even though scientists don’t fully understand the mechanisms behind them, the positive effects are strong: The clinical study was stopped ...
kcra.com9d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
THEY'RE ADVERTISED AS OZEMPIC OR WEGOVY ... though scientists don't fully understand the mechanisms behind them, the positive effects are strong: The clinical study was stopped early after ...